Nathan M. Radcliffe is a board-certified ophthalmologist who specializes in glaucoma and cataract surgery.
Dr. Radcliffe graduated Alpha Omega Alpha from Temple University School of Medicine and served as the Chief Resident at New York University during his ophthalmology residency and was the Chief Glaucoma Fellow at the New York Eye and Ear Infirmary.
Dr. Radcliffe has served as the Section Director of Glaucoma Services at NYU and Bellevue hospital and at Weill Cornell Medical Center. Dr. Radcliffe is regarded as a leader in the field of Glaucoma, more specifically in the innovations of minimally invasive, “microincisional,” glaucoma surgery.
He has been recognized as a “Top 40 Ophthalmologist Under 40” by The Ophthalmologist journal. Dr. Radcliffe has published over 50 peer-reviewed publications in glaucoma research. He is a microincisional glaucoma surgery (MIGS) innovator and instructor and was the first surgeon in New York to offer patients the Kahook Dual Blade Goniotomy, Visco360, and Trab360 (OMNI), the G6 micropulse laser, and Allergan’s Xen subconjunctival implant.
He continues to perform many microstents and MIGS surgeries each week and teaches other glaucoma specialists these techniques locally in NY, and on the national stage at the annual American Academy of Ophthalmology (AAO) and American Society of Cataract and Refractive Surgery (ASCRS) meetings. This vast experience gives Dr. Radcliffe the very unique ability to customize the most appropriate therapies, both medical, laser, and surgical, to the glaucoma patients that he serves.
Education & Training
Temple University School of Medicine, Alpha Omega Alpha
New York University, Residency in Ophthalmology, Chief Resident
New York Eye and Ear Infirmary, Chief Glaucoma Fellow